Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Study Hypothesis Evaluation of the durability of the combination Tenofovir and Hydroxyurea to
maintain viral suppression below 50 copies/ml in volunteers who have achieved viral
suppression on a standard HAART regimen.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore